Can small molecule peptides help with gastric erosion?

Generally speaking, small-molecule peptides refer to small-molecular bioactive peptides. Small-molecular bioactive peptides can be beneficial for gastric erosion. The specific analysis is as follows:

Due to their low molecular weight, small-molecular bioactive peptides can more easily penetrate cell membranes and enter cells directly, participating in cellular physiological activities and metabolic processes. This high permeability enables them to rapidly reach damaged gastric mucosal tissues and exert therapeutic effects. Small-molecular bioactive peptides also possess strong regenerative capabilities, promoting the regeneration and repair of gastric mucosal cells and accelerating the healing of eroded lesions. In the pathological process of gastric erosion, the gastric mucosa is damaged and the capacity for cell regeneration is reduced. Small-molecular bioactive peptides can stimulate cell proliferation and enhance cellular repair ability, thereby aiding recovery from gastric erosion. Additionally, these peptides exhibit certain anti-inflammatory effects by inhibiting inflammatory responses and reducing symptoms such as congestion and edema in the gastric mucosa, thus alleviating patient discomfort. Therefore, small-molecular bioactive peptides are helpful in the treatment of gastric erosion.

Small-molecular bioactive peptides are typically used as an adjunctive therapy and cannot replace primary medical treatments. Patients with gastric erosion should follow their doctors’ recommendations for standardized drug therapy, dietary adjustments, lifestyle improvements, and other necessary measures while using small-molecular bioactive peptides.